CytoSorbents Corporation, listed on NASDAQ as CTSO, is a New Jersey-based critical care company that focuses on blood purification to address life-threatening conditions in the intensive care unit and during cardiac surgery.
The company specializes in developing innovative solutions for critical care patients, offering advanced technologies to improve outcomes and save lives in high-risk medical situations.
Generated from their website's infomation